Clifford Chance represented SeaTown on Majority Acquisition of Foundation Healthcare
Singapore-based investment manager SeaTown Holdings International's private equity fund, SeaTown Private Capital Master Fund, received legal advice from international law firm Clifford Chance on its investment in Foundation Healthcare Holdings (FHH).
FHH, a Singapore-headquartered healthcare platform, was built from scratch, incorporating cutting-edge technology, and is supported by more than 50 specialists across 13 medical specialties. The platform is estimated to have pro-forma revenue of over S$130 million.
The transaction was led by partner Valerie Kong, who received support from senior associate Ivan Chan and associates Victor Leung and John Wu.
The core team was further assisted by multiple teams across the Clifford Chance network, including those focusing on financing, antitrust, regulatory, and capital markets aspects.
“We are immensely proud to support SeaTown on its investment into FHH. Singapore’s robust healthcare industry continues to be a key sector for investments by financial investors. We wish SeaTown and the FHH management team every success with their partnership,” Valerie Kong said.
Clifford Chance has a significant track record of advising on healthcare transactions in the Asia Pacific region. Its recent experience includes advising CVC on its acquisition of Xi'an Yikang Pharmacy, providing legal counsel on Sipai Health Technology's Hong Kong IPO and Listing, and assisting Prenetics in acquiring a majority stake in ACT Genomics.